DNA X Inc

DNA X Inc(SONM)股票分析

$3.310

+0.040 (+1.22%)收盤時

Loading chart…
最高
3.420
開盤
3.260
成交量加權均價
3.33
成交量
6.93K
市值
47.89M
最低
3.260
成交金額
23.09K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.

AI 分析 of DNA X Inc (SONM)

賣出

Sonim Technologies Inc is not a good buy right now due to significant financial losses and a declining stock price. The current price is $3.27, and the stock has dropped 80.61% over the past year. Additionally, the RSI is at 33.107, indicating the stock is oversold but also reflects a lack of buying momentum. The forward P/E ratio of 3.1676 suggests potential undervaluation, but the overall financial health is poor, with a net income loss of $12.47 million in the last reported quarter. The main risk is the lack of revenue, as the company reported zero revenue in multiple quarters, which raises concerns about its sustainability.

估值指標

DNA X Inc(SONM)目前預期本益比為 3.17,5 年平均預期本益比為 2.61。

預期本益比

合理
5 年均值 P/E
2.61
目前P/E
3.17
高估
12.21
低估
-6.99

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
0.05
目前EV/EBITDA
0.00
高估
4.09
低估
-3.99

預期股價營收比

低估
5 年均值 P/S
0.22
目前P/S
0.00
高估
0.36
低估
0.09

持有 SONM 的大戶

L

L1 Capital Pty. Limited

+ 持有SONM

-2.31%

3個月報酬率

SONM 常見問題 —— 由 Alphio AI 解答

DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong. It operates in the Technology sector (TELEPHONE & TELEGRAPH APPARATUS industry).

Sonim Technologies Inc is not a good buy right now due to significant financial losses and a declining stock price. The current price is $3.27, and the stock has dropped 80.61% over the past year. Additionally, the RSI is at 33.107, indicating the stock is oversold but also reflects a lack of buying momentum. The forward P/E ratio of 3.1676 suggests potential undervaluation, but the overall financial health is poor, with a net income loss of $12.47 million in the last reported quarter. The main risk is the lack of revenue, as the company reported zero revenue in multiple quarters, which raises concerns about its sustainability.

暫無貼文

註冊或登入後參與討論

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易